台股 » 個股 » 厚生 » 籌碼相關 » 券商分點績效

厚生

(2107)
可現股當沖
  • 股價
    26.80
  • 漲跌
    --
  • 漲幅
    0.00%
  • 成交量
    217
  • 產業
    上市 橡膠類股
  • 202人加入追蹤

    立即追蹤

  • 本地時間:13:35(已收盤)

     
厚生 (2107)籌碼相關-券商分點績效/獲利分析
券商分點績效/獲利分析

透過統計各券商分點在長期買賣某個股的操作績效,來找出真正獲利的贏家所在券商分點,進而追蹤此贏家所操作的股票與軌跡。

«前一日     2024/04/22     後一日»

券商獲利排行 - 2024/04/22

券商分點績效總損益(仟)己實現(仟)未實現(仟)買賣超買張賣張均價均買均賣現價
  4.33%10001009090025.725.7026.8
  2.57%79.71.877.99611922262626.126.8
  2.88%76.72.274.6821032125.925.92626.8
  4.28%70.41.868.66064425.725.726.126.8
  2.53%64.8-1.2669498326.126.125.726.8
  2.90%41.5041.5555502626026.8
  3.44%37.4-0.237.64142125.925.925.726.8
  2.53%35.60.435.245549262626.126.8
  3.24%27.7-0.528.23133225.925.925.726.8
  3.28%25.5025.5303002626026.8
  3.61%25.15.419.817271025.825.626.226.8
  2.09%230234242026.326.3026.8
  2.31%18.1117.12430626.126.126.326.8
  2.87%17.8-0.117.91824625.825.825.826.8
  2.23%16.416.400282826.22626.526.8
  2.97%15.40.315.219201262626.326.8
  3.05%12.7012.7161602626026.8
  3.23%12.50.212.41315125.925.926.126.8
  2.82%12.5012.51717026.126.1026.8
  1.58%12.5012.53030026.426.4026.8
  2.14%12.3-0.412.71922226.126.22626.8
  3.94%12.2012.21212025.825.8026.8
  1.34%11.515.3-3.8-6273325.925.626.226.8
  3.92%11.10.210.91011125.725.725.926.8
  3.21%10.80.510.4111312625.926.426.8
  2.78%10.70.310.51015525.825.825.826.8
  3.77%10.7010.71111025.825.8026.8
  4.08%10.5010.51010025.825.8026.8
  3.28%10.2010.2121202626026.8
  3.88%100101010025.825.8026.8
  2.35%9.809.81316226.126.126.126.8
  2.73%9.209.21313026.126.1026.8
  0.43%9.217.4-8.2-13708326.125.926.226.8
  2.29%9091515026.226.2026.8
  1.03%8.8-4.2131833152626.125.826.8
  2.70%8.444.4412825.925.726.226.8
  3.50%8.108.199025.925.9026.8
  3.08%808101002626026.8
  3.08%808101002626026.8
  2.46%7.616.6712525.925.926.126.8
  2.83%7.30.17.29101262626.226.8
  2.16%7.307.31313026.226.2026.8
  2.49%6.506.51010026.226.2026.8
  4.48%5.705.755025.725.7026.8
  3.13%5.705.77702626026.8
  4.28%5.505.555025.725.7026.8
  1.90%5.4-0.66.1911226.126.125.826.8
  2.29%5.405.499026.226.2026.8
  2.51%5.205.288026.126.1026.8
  1.53%5.205.21313026.426.4026.8

券商虧損排行 - 2024/04/22

券商分點績效總損益(仟)己實現(仟)未實現(仟)買賣超買張賣張均價均買均賣現價
  -2.93%-412.23.9-416.2-4816154225.925.925.926.8
  -2.38%-56.9-56.900929225.926.225.626.8
  -2.67%-54.40-54.4-7807826.1026.126.8
  -1.02%-37.73.7-41.4-51911422625.92626.8
  -1.41%-23.1-20.5-2.6-3606326.126.325.926.8
  -2.16%-221.1-23.2-3723926.125.626.226.8
  -2.05%-21.60-21.6-4004026.3026.326.8
  -3.08%-200-20-250252602626.8
  -3.41%-17.60.4-18-1822025.825.625.826.8
  -2.89%-16.60-16.6-220222602626.8
  -2.84%-16.30-16.3-2202226.1026.126.8
  -2.68%-140-14-2002026.1026.126.8
  -2.81%-13.90-13.9-1901926.1026.126.8
  -2.54%-13.3-13.300202026.226.625.926.8
  -3.27%-12.8-12.80015152626.525.626.8
  -4.48%-11.50-11.5-1001025.7025.726.8
  -0.58%-11.4-11.400767625.725.825.626.8
  -2.25%-11.3-11.300191926.326.62626.8
  -2.54%-11.2-4.3-6.9-710172626.325.826.8
  -1.17%-11-11.60.6136352626.225.826.8
  -4.57%-10.50-10.5-90925.6025.626.8
  -1.13%-103-13.1-19153426.125.926.126.8
  -3.55%-9.20-9.2-1001025.9025.926.8
  -1.65%-9.20-9.2-2102126.4026.426.8
  -2.87%-9-900121226.226.625.826.8
  -2.29%-90-9-1501526.2026.226.8
  -3.85%-8.9-0.1-8.8-81925.725.925.726.8
  -0.94%-8.70-8.7-3503526.6026.626.8
  -2.76%-8.6-1.5-7.1-84122626.325.926.8
  -2.29%-8.40-8.4-1401426.2026.226.8
  -3.21%-7.50-7.5-9092602626.8
  -3.47%-7.20-7.2-80825.9025.926.8
  -2.68%-70-7-1001026.1026.126.8
  -2.29%-60-6-1001026.2026.226.8
  -2.49%-5.80-5.8-90926.2026.226.8
  -4.28%-5.50-5.5-50525.7025.726.8
  -3.47%-5.40-5.4-60625.9025.926.8
  -2.88%-5.20-5.2-70726.1026.126.8
  -3.88%-50-5-50525.8025.826.8
  -2.39%-50-5-80826.2026.226.8
  -1.82%-4.8-4.800101026.326.626.126.8
  -2.29%-4.80-4.8-80826.2026.226.8
  -3.04%-4.7-1.3-3.5-42626.126.625.926.8
  -3.55%-4.60-4.6-50525.9025.926.8
  -2.51%-4.60-4.6-60726.125.626.126.8
  -2.12%-4.4-1.4-3-35825.926.125.826.8
  -4.23%-4.30-4.3-40425.7025.726.8
  -3.28%-4.20-4.2-5052602626.8
  -4.08%-4.20-4.2-40425.8025.826.8
  -4.08%-4.20-4.2-40425.8025.826.8
向榮生技海外布局傳捷報 通過日本厚生省細胞培養加工設施查核Anue鉅亨-2024/05/15
昱厚生技盼加速鼻噴劑型應用 推進三產品臨床試驗Anue鉅亨-2023/06/30
厚生 相關文章
厚生 相關影音